Many different syndromes are classified as mucopolysaccharidoses, and, despite remarkable progress in the biochemical understanding of these diseases, much remains to be learned and many cases still escape classification.
Mucopolysaccharidoses are inborn storage diseases, characterized by a complex accumulation of mucopolysaccharides and of glycolipids within the lysosomes. Sixteen human diseases correspond to this definition, of which nine have been presently explained by the deficiency of an acid hydrolase. They are somewhat arbitrarily divided into mucopolysaccharidoses and mucolipidoses. In mucopolysaccharidoses, mucopolysaccharides are the main storage substances, although an abnormal accumulation of complex lipids is practically always disclosed at least by the ultiastructural examination. Excessive urinary elimination of mucopolysaccharides also characterize these diseases. In mucolipidoses, mucopolysacchariduria is usually normal and the accumulation of complex lipids is more prominent, or has been recognized before that of polysaccharides.
Except for Hunter disease all these pathological conditions are autosomal recessive disorders. The present paper summarizes the main features characterizing these storage diseases, and discusses their pathogenesis.
Historical and Pathogenetic Considerations
The evolution of knowledge concerning mucopolysaccharidoses and mucolipidoses, and the successive hypotheses formulated to explain their pathogenesis illustrate how scientific progress requires the united efforts of researchers in several disciplines.
First recognized as a bone dystrophy, around 1920, the 'Hunter-Hurler syndrome' long remained an entirely unexplained inherited disorder. Pathological studies have, however, indicated that cellular alterations are generalized and not restricted to bone. Histochemical analyses first classified the syndrome with the lipidoses (Tuthill, 1934) , but later drew attention to the tissue accumulation of mucopolysaccharides (Brante, 1952 (Dorfman and Lorincz, 1957; Meyer, Grumbach, Linker, and Hoffman, 1958; Hoffman, Linker, Grumbach, and Sampson, 1959) . These provided the basis for the subdivision of the 'Hurler syndrome' into six subgroups (McKusick, Kaplan, Wise, Hanley, Suddarth, Sevick, and Maumanee, 1965) . The possibility that mucopolysaccharidoses could result from an excessive biosynthesis of mucopolysaccharides was suggested by Matalon and Dorfman (1966) .
THE LYSOSOMAL THEORY
Meanwhile, in Louvain, lysosomes had been discovered by C. de Duve (de Duve, Pressman, Gianetto, Wattiaux, and Appelmans, 1955) , their role in intracellular digestion established (for reviews, see de Duve and Wattiaux, 1966; Dingle and Fell, 1969) , and the first example of a disease (type II glycogenosis) resulting from a deficiency of a lysosomal hydrolase recognized by H. G. Hers (1961, 1963) . This finding allowed Hers to formulate the general concept of 'inborn lysosomal diseases' (see also Hers, 1965 Hers, , 1973 Van Hoof, 1969, 1970) .
Inborn lysosomal diseases have the following characteristics. (1) They are inherited storage disorders with symptoms developing progressively.
(2) The stored material accumulates within lysosomes; this can be demonstrated by ultrastructural studies. ( 3) The stored material is, as a rule, heterogeneous. Indeed, most lysosomal enzymes have little specificity concerning the lipid, polysaccharide, or glycoprotein nature of their substrate, and are only specific of one type of chemical linkage.
Deficiency of x-fucosidase, for instance, results in the simultaneous accumulation of polysaccharide fragments, of oligosaccharides originating from glycoproteins and of oligoglycosyl-ceramides, all of them containing fucose in the ox-configuration. Mucopolysaccharidoses and mucolipidoses (4) One of the lysosomal hydrolases is missing. (5) Material accumulating in patient's cells must be digestible by the enzymes present in normal lysosomes.
Hers suggested that this concept was not restricted to type II glycogenosis but applied to most of the known storage diseases, such as the lipidoses and mucopolysaccharidoses and in 1963, research was initiated, in Louvain, into the electron microscopic examination and systematic assay of lysosomal enzyme activity in tissues from patients with mucopolysaccharidoses.
THE ULTRASTRUCTURAL EVIDENCE
Ultrastructural studies disclosed, in the liver of patients with the Hurler syndrome, the enlargement of lysosomes that was predicted by the concept of 'inborn lysosomal diseases ' (Van Hoof and Hers, 1964) . Large clear vacuoles, limited by single membranes, were found in the cytoplasm of the cells, while secondary lysosomes of normal appearance ('dense bodies') had practically disappeared (fig 1) . * ....,,.: .. .: j^t 5 8;g. ,<.:$--;b&, ,.:<e~~~.
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The presence of mucopolysaccharides within lysosomes did not provide the proof that mucopolysaccharidoses result from the absence of lysosomal enzymes. As pointed out by the authors, excessive synthesis of normal macromolecules, such as mucopolysaccharides, could account for the overloading of lysosomes, if the latter took up these molecules faster than they degraded them. An example of that situation had been provided by injecting laboratory animals with dextran, a polyglucoside slowly digestible by the lysosomes (Daems, 1962; Wattiaux, 1966) . Also, although unlikely, it was possible that the mucopolysaccharide accumulated because its structure was abnormal, for example, that it contained one or more chemical bonds resistant to normal lysosomal hydrolases. Chemical analyses have not disclosed such structural abnormalities in the mucopolysaccharidoses.
Besides their role in understanding the pathogenesis ofmucopolysaccharidoses, ultrastructural investigations are helpful in the recognition of new syndromes and in prenatal diagnosis.
THE ENZYMATIC EVIDENCE
In parallel with ultrastructural studies, the activity of lysosomal hydrolases was measured in tissues from patients in the hope of finding the missing enzyme. Little interest was paid to proteolytic enzymes. Indeed, a dysfunction of lysosomal proteolysis would first result in peptide accumulation and perhaps in the storage of proteoglycans. In (Frantantoni, Hall, and Neufeld, 1968a) . The discovery of the presence in the culture medium of specific 'corrective factors' able to restore the normal catabolism of mucopolysaccharides in fibroblasts from patients (Fratantoni, Hall, and Neufeld, 1968b) Leroy and Crocker, 1966; Loeb, Cremer, and Denolin-Reubens, 1969a; Dorfman and Matalon, 1972; Spranger, 1972a) Tuthill (1934) at the necropsy on one of Gertrud Hurler's original patients, whereas, in fibroblasts, chondrocytes, and visceral parenchymal cells the content of the vacuoles is water-soluble and metachromatic, due to the presence of acid mucopolysaccharides, as first demonstrated by Brante (1952) . However, these vacuoles also frequently contain material staining as lipid (see, for instance, Wolfe, Blennerhasset, Young and Cohen, 1964) .
Electron microscopy confirms the heterogeneity of deposits, mucopolysaccharide material being electron-lucid, and complex lipids usually appearing as electron-dense lamellar deposits. But the most important contribution of ultrastructural studies in the mucopolysaccharidoses has been the demonstration of the lysosomal nature of the vacuoles (see above). In liver cells, lysosomes distended by polysaccharide material appear as clear vacuoles limited by a unit membrane. Vacuoles are frequently larger than the cell nucleus, and the dense bodies, with the normal appearance of secondary lysosomes, have disappeared (figs 3, 4) . The presence of acid phosphatase in these vacuoles was first demonstrated by Wallace, Volk, Schneck, and Kaplan (1966 (Van Hoof, 1972 , from which it was calculated that the lysosomal volume is 30-to 77-fold larger in patients than in controls. Lysosomes occupy in most patients over 20% of the cell volume. This is surprisingly large, compared with the relatively modest amount of mucopolysaccharide revealed by F. Van Borri, Hooghwinkel, and Edgar, 1966; Philippart, 1966; Clausen, Dyggve, Melchior, and Christensen Lou, 1967; Taketomi and Yamakawa, 1967; Suzuki, 1967; Wherrett, 1968; Kint, Dacremont, Carton, Hooft, and Loeb, 1971) .
ENZYMOLOGY
The causal lesion of Hurler disease is a complete lack or a profound deficiency of a-L-iduronidase. This was first suggested by Matalon, Cifonelli, and Dorfman (1971) , who observed that the release of iduronate from desulphated heparan sulphate was deficient when patient's fibroblasts were used as the source of enzyme. An artificial substrate was then synthesized by Weissmann and Santiago (1972) , who demonstrated that a-L-iduronidase is a lysosomal enzyme, at least in rat liver. With this substrate, the lack of iduronidase was unequivocally demonstrated in liver, cultured fibroblasts, and urine from Hurler patients (Bach, Friedman, Weissmann, and Neufeld, 1972; . The same lesion was found, by these authors, in the Scheie syndrome (mucopolysaccharidosis type V), indicating that types I and V are allelic disorders. The correspondance between a-L-iduronidase and the 'Hurler corrective factor', which had already been discovered by Fratantoni et al (1968b) in cultured fibroblasts, was demonstrated by Bach et al (1972) . Hers, 1967a, 1968a; Van Hoof, 1973a (Fratantoni et al, 1969) . Typing of the disease can be achieved by using the specific corrective factors, or by adding partially purified a-L-iduronidase to the culture medium (Bach et al, 1972 (Crocker, 1972; Danes, Degnan, Salk, and Flynn, 1972; Dekaban, Holden, and Constantopoulos, 1972; Erickson, Sandman, Robertson, and Epstein, 1972; Spranger, 1972b; Booth and Nadler, 1973) . The purification of the missing enzyme will, in the future, provide a much more potent and specific agent in substitution therapy. Organ transplantation should also be considered, at least in the more slowly progressive patients, for this therapeutic approach has proved successful in Fabry disease, another inborn lysosomal storage disorder (for a review, see Desnick, Bernlohr, and Krivit, 1973 (Maroteaux, 1970) . In one case a 13-fold excess of digalactosyl ceramide and a two-fold excess of digalactosylglucosyl ceramide were noted in kidney (Kint et al, 1971 ).
Hunter disease results from a deficiency of sulphoiduronate sulphatase (Bach, Eisenberg, Cantz, and Neufeld, 1973; Sjoberg, Fransson, Matalon, and Dorfman, 1973) . The presence of sulphated iduronic acid (fig 6) has been reported in dermatan sulphate (Malmstrom and Franson, 1971) and in heparin (Lindahl and Axelsson, 1971) ; the latter has a chemical structure similar to that of heparan sulphate. The Hunter corrective factor has been identified by Bach et al (1973) (Kresse, Wiesmann, Cantz, Hall, and Neufeld, 1971) , in both of which the biochemical lesion is known. Except for the enzymatic deficiency, no significant differences allow these subgroups to be distinguished. Chemical analysis indicates that heparan sulphate is the only, or at least, the predominant mucopolysaccharide accumulated and excreted. This polysaccharide, although its chemical structure is closely related to heparin, has only negligible effects on blood coagulation. No disease resulting from the accumulation of heparin has ever been reported.
Sanfilippo A disease is due to a profound deficiency of a specific sulphatase, which acts on the Nsulphate groups present in heparin and heparan sulphate (Kresse and Neufeld, 1972; Kresse, 1973 (Kresse, 1973) .
In Sanfilippo B disease, N-acetyl-a-glucosaminidase is virtually absent from all the tissues tested: fibroblasts, liver, kidney (O'Brien, 1972; Figura and Kresse, 1972) . We were recently able to show that the enzymatic defect can also be demonstrated in blood plasma (table I). The identity of the Sanfilippo B factor with N-acetyl-a-glucosaminidase has been elegantly established by von Figura and Kresse (1972) . The lysosomal nature of this enzyme had been proved in pig liver (Weissmann et al, 1967) and beef liver (Weissmann and Hinrichsen, 1969) .
As already discussed in the case of Hurler and Hunter diseases, the enzymatic defect responsible for Sanfilippo A disease does not account for the deposition of complex lipids. This is less evident for the N-acetyl-oa-glucosaminidase defect, for many glycolipids contain N-acetylglucosamine of which the aor fl-configuration has not always been clearly ascertained. As in Hurler and Hunter disease, liver acid f-galactosidase activity is frequently lower than one fifth of the mean control value, but normal activity is found in one out of three patients with the Sanfilippo syndrome. Hyperactive lysosomal hydrolases are the same as in the first two types of mucopolysaccharidosis. PRENATAL 
DIAGNOSIS, HETEROZYGOTE DETECTION, AND THERAPEUTIC ATTEMPTS
These have been performed as in mucopolysaccharidosis type I and II, and treatment by plasma or leucocyte transfusions has been attempted (Dean, Muir, and Benson, 1973 (Spranger, 1972a; Maroteaux, 1973 (Panizon, Sartorelli, and Perona, 1968; Tondeur and Loeb, 1969) . Chondrocytes in epiphyseal plates are distended by numerous clear vacuoles (Maynard, Cooper, and Ponseti, 1973) . Ultrastructural studies of other tissues have not, to our knowledge, been reported.
Mucopolysacchariduria is less than in Hurler disease. Keratan sulphate in urine is reported to be between two to three times (Linker, Evans, and Langer, 1970) and 400 times the normal value (Kaplan, McKusick, Trebach, and Lazarus, 1968) . Lipid analysis of brain tissue has not, to our knowledge, been performed.
ENZYMOLOGY
The enzymatic defect responsible for the Morquio syndrome has not yet been discovered. The activity of the liver acid hydrolases is much less abnormal than in types 1-111; /3-glucuronidase and N-acetyl-/-hexosaminidase are frequently hyperactive (Van Hoof, 1972 . It is remarkable that no deficiency of acid /-galactosidase has been found in this disease which is characterized by the elimination of the only mucopolysaccharide to contain galactose. Wiedemann, and Zellweger (1970) , and Spranger (1972a) distinguish a slowly evolving form, where death usually is due to heart failure, from a rapidly evolving form, in which skeletal and corneal lesions are extreme. Urine contains an excess of dermatan sulphate; heparan sulphate excretion is normal (Maroteaux et al, 1963) .
The ultrastructure differs from that in Hurler disease by the much more moderate storage of electron-lucid material in lysosomes of hepatocytes (figs 7-8), while liver fibroblasts and Kupffer cells are at least as heavily loaded with mucopolysaccharides as in mucopolysaccharidosis type I (fig 7) . Ocular tissues also contain numerous clear cytoplasmic vacuoles (Kenyon, Topping, Green, and Maumenee, 1972) .
In accord with the ultrastructural appearances, chemical analysis of liver tissue reveals a smaller amount of stored mucopolysaccaride than in mucopolysaccharidosis types I-l11: in the latter diseases mucopolysaccarides are about 25-75 times normal, while, in Maroteaux-Lamy disease, a 13-fold increase has been measured (Van Hoof, 1972) . factor is presently under study (Barton and Neufeld, 1972) . The activity pattern of the liver acid hydrolases resembles that in Sanfilippo disease. /-Galactosidase (and a-arabinosidase) are hypoactive (down to 150% of controls) in some cases, and normal in others.
Chondroitin 4-Sulphaturia
Chondroitin 4-sulphate is the major normal urinary mucopolysaccharide (Varadi, Cifonelli, and Dorfman, 1967 ) and its excretion remains normal in most cases of mucopolysaccharidosis. Philippart and Sugarman (1969) , Campailla and Martinelli (1969) , Spranger, Schuster, and Freitag (1971) (Hickman and Neufeld, 1972; Hall, Cantz, and Neufeld, 1973; Neufeld and Cantz, 1973) , are almost completely deficient in /3-glucuronidase. As in other types of mucopolysaccharidoses, cultured fibroblasts from patients accumulate large amounts of radioactive polysaccharides, when radioactive sulphate is added to the culture medium. This accumulation can be corrected by the addition of bovine 3-glucuronidase to the medium. Correction was also achieved by Lagunoff, Nicol, and Pritzl (1973) (Sly et al, 1973) . /3-D-Glucuronidase is a lysosomal enzyme (de Duve et al, 1955) and so this deficiency is another lysosomal storage disease.
Mucolipidosis Type I
This still imperfectly defined syndrome has been diagnosed in about 10 patients. The first cases were reported by Wiedemann and Spranger (1968) and by Spranger, Wiedemann, Tolksdorf, Graucob, and Caesar (1968) Wiedemann, 1970a, 1970b) . Liver acid hydrolases have now been analyzed in seven cases (Van Hoof, 1972 . The mean $-galactosidase activity is five times greater than normal. The hyperactivity of other hydrolases, such as a-fucosidase, f-hexosaminidase (seven-fold increase), a-galactosidase and ,-glucuronidase (sixfold increase) indicate lysosomal dilatation. Ultrastructure shows that the clear vacuoles frequently contain numerous osmiophilic droplets Loeb etal, 1969d; Freitag, Bliimcke, and Spranger, 1971a; Van Hoof and Hers, 1972) .
Clinically, the syndrome is less homogeneous. Gargoyle-like facial dysmorphism and Hurler-type dysostosis were always present but varied largely in extent. Some patients suffered from peripheral neuropathy with myelin degeneration (1971) ; Van Hoof (1972 and Gilbert et al (1973) (see also fig 9) . The content of these inclusions is variable, mostly depending on the time elapsed since the last subculture. At first relatively homogeneous and osmiophilic, the granules become progressively loaded with pleomorphic material strongly suggestive of defective digestion of autophagic residues (Van Hoof, 1972 . By all the evidence the inclusions are lysosomes. Morphometric analysis of electron micrographs indicates that lysosomes in I-cell disease are six times more numerous than in control fibroblasts, and that their diameter is about 60% larger than in controls. The relative volume occupied by lysosomes is thus increased from 12o% to 27 % of the total cell volume.
The presence of I-cells in fibroblast cultures is not strictly pathognomonic of mucolipidosis type II. They can also be induced by adding antilysosomal antibodies (Tulkens, Trouet, and Van Hoof, 1970 ; see also fig 10) or chloroquine to the culture medium, or simply by buffering the medium at pH 8 6 (Lie, McKusick, and Neufeld, 1972; Lie, Schofield, Taylor, and Doty, 1973) . Another interesting observation, made in fibroblasts from a patient of Dr J. Spranger, in Kiel, was the progressive appearance of I-cells after the fourth subculture (fig 11) .
Chemical analysis of I-cells by Hof, Matalon, and Dorfman (1971) disclosed a two-fold inicrease of the lipid content of the cells. When fibroblasts were cultured in the presence of calf serum, lipid-bound neuraminic acid (gangliosides) and total haematoside were both approximately eight-fold more abundant in relation to the protein content than in normal cells. There was a similar eight-fold excess in GM3-and GD3-gangliosides. Dawson, Matalon, and Dorfman (1972) and Leroy, Ho, MacBrinn, Zielke, Jacob, and O'Brien (1972) confirmed the lipid accumulation, but found no abnormal storage of mucopolysaccharides in I-cells.
The first enzymatic studies of I-cells, by Leroy and DeMars (1967) , indicated that /-glucuronidase activity was low but not totally absent. In addition, the activity of acid /-galactosidase, 3-hexosaminidase, and a-fucosidase was found deficient in fibroblasts from the patient reported, in 1968, by Matalon et al, who most probably suffered from mucolipidosis type II, according to Dorfman and Matalon (1972;  Mucopolysaccharidoses and nzucolipidoses Fig 10 Ratfibroblasts c,.lItured in the presence ofgammaglobulin from a rabbit immunized against the soluble constituents ofpurified rat liver lysosomes (Tulkens et al, 1970) . Ultrastructural alterations are similar to those in I-cells.
Van Hoof, unpublished results). The fact that many lysosomal hydrolases are deficient in I-cells is now widely documented (Leroy and Spranger, 1970; Lightbody, Wiesmann, Hadom, and Herschkowitz, 1971; Tondeur et al, 1971; Leroy et al, 1972) . Inhibition of some acid hydrolases was also demonstrated in fibroblasts in which I-cell-like lesions had been induced, as rat fibroblasts cultured in the presence of antibodies directed against the soluble constituents of lysosomes (Tulkens et al, 1970) and normal human fibroblasts cultured in a medium brought to pH 8 with TES buffer (Lie et al, 1972 . Different pathogenic interpretations have been proposed to explain this enzyme deficiency which involves several acid hydrolases. Wiesmann, Lightbody, Vassella, and Herschkowitz, (1971a) and Wiesmann, Vassella, and Herschkowitz (1971b) suggested that it results from leakage of acid hydrolases through abnormally permeable lysosomal membranes. To support this interpretation the authors stressed that acid hydrolases are much more abundant in the culture medium of I-cells than when control fibroblasts are grown. The argument was reinforced by the fact that acid hydrolases are also hyperactive in the serum of patients (Wiesmann et al, 1971b) and sometimes even of heterozygotes (Leroy and van Elsen, 1973) . The suggested pathogenic mechanism does not take into account, however, that increased permeability of lysosomal membranes will first result in the leakage of acid hydrolases in the cytoplasm of the cell itself and, as a consequence, will damage the cell, as foreseen in the 'suicide bag' hypothesis (for a theoretical discussion, see Novikoff, 1973 lum, concentrated in the Golgi apparatus, from which coated vesicles bud off (primary lysosomes) and F. Van Hoof later fuse with preexisting lysosomes or digestive vacuoles (for reviews, see Novikoff, 1963 Novikoff, , 1973 Duve and Wattiaux, 1966 (Neufeld, 1973) (Vaes, 1968; Novikoff, 1973 Danes and Bearn (1966) . kidney, or spleen from patients (Leroy et al, 1972; Van Hoof, 1972) .
The enzymology of visceral tissues does not reflect the polyenzymatic deficiency characteristic of I-cells. Liver acid hydrolases measured in 13 cases displayed little significant abnormality (Van Hoof, 1972 (Tondeur et al, 1971 however, lacking. X-ray examination reveals skeletal changes resembling the milder forms of the Hurler syndrome: these include claw hands, flattening of the femoral epiphyses, platyspondyly, and flaring of the iliac wings (Melhem, Dorst, Scott, and McKusick, 1973) . Vacuolated cells are present in bone marrow, as in Hurler disease (Maroteaux and Lamy, 1966) .
Ultrastructure of liver parenchymal cells shows only slightly enlarged secondary lysosomes, in which abnormal storage is not obvious (fig 13) . Kupffer cells are relatively rich in unstructured osmiophilic materials. Cultured fibroblasts display somewhat enlarged lysosomes, which contain mostly lamellar and vesicular structures (fig 14) . The cytoplasmic changes in these cells are much less important than in I-cell disease. Quigley and Goldberg (1971) reported the presence of clear vacuoles in conjunctival fibroblasts. Gonatas and Gonatas (1965) , and Ledeen, Salsman, Gonatas, and Taghavy (1965) discovered the nature of the main accumulated lipid. Derry, Fawcett, Andermann, and Wolfe (1968) suggested that cases with later onset and moderate visceromegaly were suffering from a distinct form of GMi-gangliosidosis. Although presently widely accepted, this subdivision of the disease does not rest on undisputable enzymatic evidence (Suzuki, Crocker, and Suzuki, 1971; Van Hoof, 1973b) . GMi-Gangliosidosis has also been described in cats (Baker, Lindsey, McKhann, and Farrell, 1971; Handa and Yamakawa, 1971 ). Slightly enlarged lysosomes in the peribiliary area of hepatocytes. The content of these dense bodies is lipofuscin-like, except for some finely granular material. In the early infantile form, symptoms may be present at birth and life expectancy is from one to two years. Some synmptoms evoke an impression of the Hurler syndrome, especially the facial dysmorphism, macroglossia, skeletal deformities, and distended abdomen due to hepatosplenomegaly. Lung and upper respiratory tract infections are frequent. Circulating and bone marrow white blood cells contain metachromatic vacuoles. Another part of the clinical picture suggests a lipidosis, such as the early impairment of psychomotor development, hypotonia followed by spasticity, convulsions, and amaurosis sometimes with macular cherry red spot. X-ray examination discloses the same skeletal deformities as in the Hurler syndrome. Mucopolysacchariduria is quantitatively normal, but an excess of keratan sulphate has occasionally been noted (R. Humbel, personal communication).
GMi-Gangliosidosis
In the late infantile form, symptoms were detected only between 6 months and 1-years; death occurred between 3 and 10 years of age. Visceromegaly and x-ray abnormalities are minimal and the clinical picture is dominated by the progressive psychomotor disturbances. Seizures are frequent and usually resistant to anticonvulsant drugs. First hypotonic, the patients become spastic in the later stages of the disease. They usually die from intercurrent infections.
Clinical differences between the early and late infantile forms of GMi-gangliosidosis are not more important than the variations currently noted among patients suffering from type II glycogenosis (Hers and Van Hoof, 1968; Hers and de Barsy, 1973) , from fucosidosis (see below), and from many other lysosomal storage diseases (Hers, 1973; McKusick, 1973 (Derry et at, 1968) .
Ultrastructural studies disclose lesions similar to those in Hurler disease: lamellar inclusions in neuronal lysosomes, first described by Gonatas and Gonatas (1965) , and clear vacuoles in visceral organs (Sacrez et al, 1967; Van Hoof and Hers, 1967b) . Morphometric analysis of liver micrographs indicates that the lysosomal volume increases at least as much as in the Hurler syndrome, with an extreme diversity in the size of the vacuoles, a few lysosomes being barely affected while others may exceed 20 microns in diameter, with a volume approximately 50 000 times that of dense bodies in control livers (Van Hoof, 1973a) . Fine tubular elements, first reported by Suzuki, Suzuki, and Chen (1968 a and b) , are frequently found in these vacuoles, especially in Kupffer cells (fig 15) . As in the Hurler syndrome intestinal absorptive cells contain large lysosomes with a finely granular matrix, different from the clear vacuoles present in most types of cells Ginsel et al, 1973) .
CHEMISTRY
The structure of the major lipid accumulating in tissues was recognized almost simultaneously by O'Brien et al (1965) and Ledeen et al (1965) . GM1-Ganglioside, or monosialo-ganglioside, constitutes approximately 900% of the ganglioside in the grey matter. In brain, its asialo-derivative is also in excess (Suzuki and Chen, 1967) . Suzuki, Suzuki, and Kamoshita (1969) Hers, 1967b) and proved by chemical analysis (Suzuki, 1968; Suzuki et al, 1969 Hoof and Hers, 1968a) , as first demonstrated in the case reported by Sacrez et al (1967) . The enzyme defect, confirmed by O'Brien (1968, 1969) , is generalized and can be detected in tissues, in plasma or white blood cells, and in urine. Only the most acid form of f-galactosidase is affected; activities recorded at pH 6-5 or 9 are approximately normal. Acid 3-galactosidase is a lysosomal enzyme, as demonstrated in rat liver (Sellinger, Beaufay, Jacques, Doyen, and de Duve, 1960), and spleen (Bowers and de Duve, 1967) . MacBrinn, Okada, Ho, Hu, and O'Brien, (1969) have shown that the tissues 82 of patients contain almost no ,B-galactosidase able to hydrolyse not only GMi-ganglioside and synthetic substrates, but also the keratan sulphate-like material isolated from livers of patients, or desialated fetuin. Acid a-arabinosidase is also barely active and sometimes totally absent.
Many acid hydrolases are hyperactive in GMigangliosidosis. In liver, N-acetyl-a-galactosaminidase is about 12 times more active than in controls, agalactosidase eight-fold, /3-hexosaminidase sevenfold, and many other glycosidases, to a lesser extent (Van Hoof, 1973b) . The reason for these secondary enzyme hyperactivities is probably the same as in the Hurler syndrome. Prenatal detection has been achieved in GM1-gangliosidosis. The amniotic fluid has been found totally deprived of (Lowden, Cutz, Conen, Rudd, and Doran, 1973) or deeply deficient in acid 3-galactosidase (Kaback, Sloan, Sonneborn, Herndon, and Percy, 1973) . These two groups of authors have shown that cultured amniotic cells have less than 5 % of the normal /3-galactosidase activity, and that the tissues of affected fetuses, aged 17 and 21 weeks, already displayed the ultrastructural alterations which characterize the disease.
Fucosidosis
The clinical syndrome corresponding to fucosidosis was recognized by Durand, Borrone, and Della Cella (1966) and reported under the title 'A new mucopolysaccharide-lipid storage disease?'. Liver ultrastructure was typical in the two original patients (Van Hoof and Hers, 1967b) and allowed the recognition of a third case (Loeb, Tondeur, Jonniaux, Mockel-Pohl, and Vamos-Hurwitz, 1969b; Loeb, Tondeur, Resibois, Jonniaux, and Van Hoof, 1969c) . The discovery of the enzyme defect (Van Hoof and Hers, 1968a and b) helped to unravel the nature of the stored substances: fucose-containing polysaccharides and glycolipids.
CLINICAL FEATURES These are difficult to summarize, so large are their variations. Eight cases have been reported in children: two by Durand et al (1966) , Durand, Philippart, Borrone, Della Cella, and Bugiani (1967) , Durand, Borrone, and Della Cella (1969a) , Durand, Phillipart, Borrone, and Della Cella (1969b) , one by Loeb et al (1969b and c) , one by Freitag et al (1971b) , Voelz, Tolksdorf, Freitag, and Spranger (1971) , two siblings, patients of Dr Donnell of Los Angeles, reported by Zielke, Veath, and O'Brien (1972) , one in Japan by Matsuda, Arashima, Anakura, Ege, and Hayata (1973) , and one by Borrone, Gatti, Trias, and Durand (1974) .
F. Van Hoof
These patients present with more or less marked Hurler-like features such as bone deformities, hepatosplenomegaly, thickness of the skin, tendency to herniae, and heart enlargement. Neurological changes are prominent in some cases and minimal in others. Death occurs usually between 4 and 6 years of age. Circulating white blood cells are vacuolated, but there is no excessive mucopolysacchariduria. The concentration of sweat electrolytes has occasionally been elevated.
Four further cases, with slower evolution and presenting with angiokeratoma corporis diffusum, have recently been reported. The first, now 21 years old, has severe physical and mental retardation: he was never able to walk or talk. The face shows gargoyle features. From the age of 4, he suffered from clinical angiokeratoma corporis diffusum, which pointed the diagnosis toward Fabry disease. a-Galactosidase, however, was normal, while a-Lfucosidase activity was less than 10% in leucocytes and urine (Patel, Watanabe, and Zeman, 1972; Epinette, Norins, Drew, Zeman, and Patel, 1973) . Another case, reported by Gatti, Borrone, Trias, and Durand (1973) and by Borrone et al (1974) , is a 17-year-old boy. He also has a long history of somatic and psychomotor retardation, recognized around the age of 1. Angiokeratoma corporis diffusum appeared when he was 5-6 years old. He now presents with spasticity and Hurler-like features, but without visceromegaly. a-Fucosidase activity was 5 % of the controls in serum and 7 % in leucocytes.
Two brothers, aged 9 and 41 years respectively, have recently been briefly reported by Kousseff, Beratis, Danesino, and Hirschhorn (1973) with a similar clinical picture: mild facial and bone dysplasia, slowly progressive psychomotor retardation, and angiokeratoma corporis diffusum. There were neither hepatosplenomegaly nor coineal opacities. a-Fucosidase was severely deficient in cultured fibroblasts.
Repeated respiratory infection has been noted in practically all cases of fucosidosis.
PATHOLOGICAL DATA Gross pathological and light microscopic lesions in patients with the severe form of the disease are reminiscent of the Hurler syndrome with, in addition, a strawberry-like alteration of the gallbladder. Another difference is that brain neurones accumulate little lipid, but instead a PAS-positive material, soluble in water and resistant to amylase, while visceral tissues contain substantial lipid as well as polysaccharide deposits.
Ultrastructure of liver is quite typical (fig 16) . Cytoplasmic clear vacuoles, which correspond to lysosomes dilated by polysaccharide, frequently contain large amounts of complex lipids, which appear as lamellated osmiophilic structures (Van Hoof and Hers, 1967b; Van Hoof, 1973c) . Both types of material are contrasted by silver nitrate after periodic acid oxidation (Loeb et al, 1969b) , indicating the presence of vicinal glycol groups. Brain neurones contain numerous cytoplasmic clear vacuoles and only rarely membranous material (Loeb et al, 1969b; Resibois, Tondeur, Mockel, and Dustin, 1970) . Cultured skin fibroblasts are rich in clear vacuoles that often contain lamellar inclusions (fig 17) . In the adult patient reported by Patel et al (1972) and Epinette et al (1973) clear vacuoles were present in fibroblasts, in keratinocytes, and in capillary endothelial cells.
Chemical studies disclose the presence in tissues of different types of fucosides. From liver tissue, a water-soluble fraction, precipitable in the presence of cetylpyridinium chloride after proteolytic digestion, was extracted by Van Hoof and Hers (1968a) . This fraction, considered to be mucopolysaccharide, contained significant amounts of fucose. Philippart (1969) isolated from livers of the same patients glycopeptides and oligosaccharides, both containing fucose and displaying antigenic activity of the Lea type. Different fucose-containing glycolipids were extracted from patient's tissues (Durand et al, 1967; Durand, Borrone, Della Cella, and Phillipart, 1968; Philippart, 1969 Philippart, , 1972 Loeb et al, 1969b; Dawson and Spranger, 1971; Voelz et al, 1971; Dawson, 1972) . These ceramide tetra-and pentasaccharides disclose H and Lea antigenicity.
ENZYMOLOGY
Fucosidosis is due to a total defect (Van Hoof and Hers, 1968a and b) or a profound deficiency of a-Lfucosidase. The defect has been confirmed in all the tissues tested, as well as in plasma and urine. The recent introduction by Koch-Light Ltd (Colnbrooks, Bucks) of a fluorogenic substrate has rendered afucosidase assay both easy and extremely sensitive. a-L-fucosidase is a lysosomal enzyme. This could be deduced from the data of Conchie and Hay (1963) and has been verified in rat liver after injection of Triton WR-1339 (Van Hoof, 1973c .
Many other lysosomal hydrolases are hyperactive in fucosidosis. The largest hyperactivities in liver concern N-acetyl-a-galactosaminidase (over six times the controls), a-galactosidase and ,-xylosidase (over five times), a-glucosidase and palmitate ester-ase, over four times the normal value (Van Hoof, 1973c) .
Prenatal diagnosis has, to our knowledge, never been achieved, but is feasible since amniotic fluid and cultured amniotic cells contain a-fucosidase. We have, however, frequently noted that the enzyme disappears from fibroblasts after repeated subcultures. If this occurs also with cultured amniotic cells, it could result in a false diagnosis.
Heterozygote detection has been attempted by Borrone et al (1974) (Jolly, 1970 (Jolly, , 1971 Hocking et al, 1972; Jolly and Blakemore, 1973) . The disease has been carefully studied by ultrastructural and enzymatic analyses, and large-scale detection of heterozygote calves has been achieved.
CLINICAL FEATURES
These recall the Hurler syndrome and sometimes aspartylglycosaminuria and begin during the first year of life. They include moderate facial dysmorphism, with prominent forehead and protruding tongue, corneal opacities (usually discrete), vertebral deformities, hepatosplenomegaly and slowly progressive psychomotor retardation. These patients are also abnormally susceptible to infection. The original patient died at the age of 4 yr 4 mth; the other patients were still alive in 1973, the oldest aged 10 (Ockerman, 1967 (Ockerman, , 1973 Norden, Ockerman, and Szabo, 1973b clear vacuoles (Ormos, Monus, Szabo, and Csapo, 1971; Rapola, 1972) . Water extracts from liver and brain contain a large excess of mannose, while no excess of mannose could be demonstrated in the lipids extracted from these tissues. Analysis of the mannose-rich compounds indicates a predominance of oligosaccharides with three to eight residues and deprived of uronic acid, which are probably residues of glycoprotein digestion. Minor mannose-containing fractions were macromolecular or were retained by anion-exchange chromatography (Ockerman, 1969 (Ockerman, , 1970 (Ockerman, , 1973 .
Urinary oligosaccharides rich in mannose are of diagnostic value (Ockerman, Norden, and Szabo, 1972; Norden, Eriksson, Hultberg, and Ockerman, 1973a; Norden et al, 1973b) . ENZYME STUDIES All a-mannosidase activity is not absent from tissues of patients (Ockerman, 1967) . DEAE-cellulose chromatography separates three forms of liver amannosidase, two are maximally active at pH 4*4, and a third has an optimal pH of 6-0. The first two forms only are lacking in patients (Carroll, Dance, Masson, Robinson, and Winchester, 1972) . Acid amannosidase is a lysosomal enzyme (Conchie and Hay, 1963; Bowers and de Duve, 1967) . Some other acid hydrolases are hyperactive in mannosidosis: in liver, for instance, N-acetyl-3-hexosaminidase, /-glucuronidase, 3-galactosidase, a-glucosidase, and afucosidase activities are frequently increased more than three-fold (Ockerman, 1967; Rapola, 1972; Norden et al, 1973b ).
Mucosulphatidosis
This rare disease was first recognized by Austin (1965) in two siblings, brother and sister, presenting with a late infantile metachromatic leucodystrophy associated with signs of gargoylism. Many descriptive names have been used, from 'link with gargoylism' (Austin, 1965) , to 'metachromatic leucodystrophy variant', 'trisulphatase or multiple sulphatase deficiency' (Austin, 1973a and b) . The name of 'mucosulphatidosis' was proposed by Rampini, Isler, Baerlocher, Bischoff, Ulrich, and Pluss (1970) .
CLINICAL AND BIOLOGICAL FEATURES
These are reminiscent of both mucopolysaccharidosis and sulphatidosis (metachromatic leucodystrophy). A somewhat coarse facial appearance, minor bone dysplasia, mild hepatosplenomegaly, excessive mucopolysacchariduria, vacuolated white blood cells in bone marrow and in circulating blood, together with the Alder granulation abnormality, point the diagnosis towards the mucopolysaccharidoses. On the other hand, the evolution of the neurological defect, increased CSF protein, reduced nerve conduction velocity, and the presence of goldenbrown metachromatic granular bodies in urine are signs of metachromatic leucodystrophy. The disease becomes evident around 1 year of age and occurs between 3 and 12 years (Austin, 1965, and b; Thieffry, Lyon, and Maroteaux, Bischoff and Ulrich, 1967; Rampini et al, Murphy, Wolfe, Balazs, and Moser, 1971 Hers, 1972; Van Hoof, 1973a , see also fig 18) . Similar alterations were found in fibroblasts from kidney interstitial tissue, while cells of the distal tubules contain, as in sulphatidosis, prismatic stacks of lipid leaflets (Tondeur, 1973) . Ultrastructural alterations in peripheral nerve cells are the same as in metachromatic leucodystrophy (Bischoff and Ulrich, 1967) . Small clear cytoplasmic vacuoles are present in lymphocytes and cultured fibroblasts (Lyon, Hors-Cayla, Jonsson, Maroteaux, 1973) .
The mucopolysaccharides excreted in urine are a mixture of heparan and dermatan sulphate (Rampini et al, 1970) . Not all cases, however, have a significant excess of mucopolysacchariduria (Austin, 1973a; R. Humbel, personal communication (Viala and Gianetto, 1955) , is practically inactive in brain, liver, kidney, urine (Austin, 1965) , and leucocytes (Van Hoof, 1972) . The enzyme protein, however, can be demonstrated immunologically (Austin, 1973a and b) .
The activity of arylsulphatase B, also lysosomal (Roy, 1958) , is markedly decreased in brain and kidney (Austin, 1965) . In two recent cases, we found it to be approximately 25% in liver and, in brain, 50 % of the normal activity.
The microsomal (Roy, 1958) sulphatase C, optimally active near neutral pH on p-nitrophenylsulphate, is also markedly reduced in mucosulphatidosis (Austin, 1965, 1973a and Murphy et al, 1971) . The inability of the patient's tissues to hydrolyse steroid sulphates (Murphy et al, 1971; Moser, Sugita, Harbison, and Williams, 1972) or 4-methylumbelliferyl sulphate around neutral pH (Van Hoof, 1972 are probably expressions of the sul-F. Van Hoof phatase C deficiency. In two recent cases we found liver methylumbelliferyl sulphatase at pH 7-4 to be 13 % and 14 % of controls. PAPS-sulphatase appears relatively spared (Austin, 1973a and 
b).
The most probable explanation for this multienzyme deficiency is to assume a defect in the synthesis of a peptide chain common to the various hydrolases acting on sulphated substrates.
Other acid hydrolases have been measured in patients. /3-Galactosidase activity is reduced in liver, kidney, cerebral cortex, leucocytes, and urine (Austin, 1965, 1973a and Murphy et al, 1971; Moser et al, 1972; Van Hoof, 1972 . Many other hydrolases are hyperactive, mostly /3-hexosaminidase (about 10-fold the normal activity), afucosidase and a-mannosidase (about five-fold), in the cases we have studied.
Other Related Disorders Several patients have been described as suffering from a 'mucopolysaccharidosis without mucopolysacchariduria', or presenting with uncommon features so that they could not be classified among the known mucopolysaccharidoses or mucolipidoses (see, for instance, Gollance and d 'Amico, 1967; Marchal, Grignon, Humbel, Vidailhet, Fall, Grignon, Pierson, and Neimann, 1968; Winchester, Grossman, Lim, and Danes, 1969; Brown and Kuwabara, 1970 (Van Hoof, 1972 ; see also fig 19) . a-Galactosidase, /-glucuronidase, and/3-glycerophosphatase were about three times more active than in controls; 11 other acid hydrolases were in the normal range.
It is not impossible that this girl suffered from a syndrome related to that reported by Diebold et al (1972) Starting with the 527 patients compiled by Hienz (1960) in the world literature, it can be estimated that well over 1000 patients with the Hurler syndrome have been reported by now. Spranger (1972a) , from these data and from his own experience, estimates the frequency of mucopolysaccharidoses with mucopolysacchariduria at about 1 case in 30 000 births in Caucasians. Mucolipidoses have been more recently defined; even for that most frequently diagnosed (GMi-gangliosidosis) fewer than 100 cases have been reported. (see fig 11) .
From the Ginsel et al, 1973) .
HOW DO NORMAL LYSOSOMES DIGEST MUCO-POLYSACCHARIDES ?
Most mucopolysaccharides exist in tissues as extracellular proteoglycan complexes (for a review, see Muir, 1973 Vaes, 1973) . There are indications that the role of lysosomal proteolytic enzymes is not restricted to the lysosomal apparatus and that these hydrolases may, in some instances, be excreted from lysosomes into the extracellular spaces and release chondroitin sulphate from the cartilage matrix (Fell and Dingle, 1963; Barrett, 1966) .
The digestion of the polysaccharide part of proteoglycans necessitates the action of several enzymes.
Most of them are needed for the hydrolysis of osidic linkages. Glycosidases acting on all the presently known osidic linkages have been demonstrated and most are found to be lysosomal enzymes. This is the case for f-xylosidase, /3-galactosidase, a-mannosidase, and aspartyl-N-acetyl-3-glycosaminidase, which are mostly necessary for the digestion of the cligosaccharide bridges; and also for ,B-glucuronidase, a-iduronidase, a-fucosidase, N-acetyl-f/-hexosaminidase, and N-acetyl-a-glucosaminidase, whose conjugated action is needed to hydrolyse glycosaminoglycans (for reviews, see Van Hoof, 1972; Muir, 1973; Vaes, 1973 Some experiments suggest that regulatory mechanisms exist, which decrease the rate of heterophagy, when lysosomes are distended. In cultured fibroblasts, for instance, there seems to be a limit to the relative volume that lysosomes can occupy: 25-27 % of the cell volume (Van Hoof, 1972 . The same limit is found in I-cells and in rat fibroblasts cultured in the presence of antilysosome antibodies. In the latter cells, it has been shown that, while the digestion of fluorescein-labelled y-globulin was stopped by the treatment, this protein did not accumulate in excessive amounts in the cells, indicating that capture by endocytosis had been reduced (Tulkens et al, 1970) .
Another effect of lysosomal dilatation is the increase in the activity of lysosomal hydrolases. This phenomenon has been demonstrated in experimental conditions (for a review, see Lloyd, 1973) and is currently observed in practically all inborn lysosomal disorders (Hers, 1973) .
The mechanism by which the accumulation of materials within lysosomes results in the cell dysfunction or death remains largely conjectural.
